Comprehensive Assessment of CFTR Modulators’ Therapeutic Efficiency for N1303K Variant
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052770 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Efremova und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moscow 115522, Russia. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, Aminophenols, Aminopyridines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Higher Education of the Russian Federation, Federal State Funded Research Institution “Research Centre for Medical Genetics”.
Abstract (Originalsprache)
p.Asn1303Lys (N1303K) is a common missense variant of the CFTR gene, causing cystic fibrosis (CF). In this study, we initially evaluated the influence of CFTR modulators on the restoration of N1303K-CFTR function using intestinal organoids derived from four CF patients expressing the N1303K variant. The forskolin-induced swelling assay in organoids offered valuable insights about the beneficial effects of VX-770 + VX-661 + VX-445 (Elexacaftor + Tezacaftor + Ivacaftor, ETI) on N1303K-CFTR function restoration and about discouraging the prescription of VX-770 + VX-809 (Ivacaftor + Lumacaftor) or VX-770 + VX-661 (Ivacaftor + Tezacaftor) therapy for N1303K/class I patients. Then, a comprehensive assessment was conducted on an example of one patient with the N1303K/class I genotype to examine the ETI effect on the restoration of N1303K-CFTR function using in vitro the patient’s intestinal organoids, ex vivo the intestinal current measurements (ICM) method and assessment of the clinical status before and after targeted therapy. All obtained results are consistent with each other and have proven the effectiveness of ETI for the N1303K variant. ETI produced a significant positive effect on forskolin-induced swelling in N1303K/class I organoids indicating functional improvement of the CFTR protein; ICM demonstrated that ETI therapy restored CFTR function in the intestinal epithelium after three months of treatment, and the patient improved his clinical status and lung function, increased his body mass index (BMI) and reduced the lung pathogenic flora diversity, surprisingly without improving the sweat test results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for Medical Genetics, Moscow 115522, Russia.
- Moscow Regional Research and Clinical Institute ("MONIKI"), Moscow 129110, Russia.
- Pulmonology Scientific Research Institute under Federal Medical and Biological Agency of Russian Federation, Moscow 115682, Russia.
ORCID-Profile: Nataliya Kashirskaya, Yuliya Melyanovskaya, Elena Kondratyeva, Tatiana Bukharova, Rena Zinchenko
Förderung
- The Ministry of Science and Higher Education of the Russian Federation
- Federal State Funded Research Institution “Research Centre for Medical Genetics”
Zitieren
APA
Efremova, A., Kashirskaya, N., Krasovskiy, S., Melyanovskaya, Y., Krasnova, M., Mokrousova, D., Bulatenko, N., Kondratyeva, E., Makhnach, O., Bukharova, T., Zinchenko, R., Kutsev, S., & Goldshtein, D. (2024). Comprehensive Assessment of CFTR Modulators’ Therapeutic Efficiency for N1303K Variant. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052770
Vancouver
Efremova A, Kashirskaya N, Krasovskiy S, Melyanovskaya Y, Krasnova M, Mokrousova D, et al. Comprehensive Assessment of CFTR Modulators’ Therapeutic Efficiency for N1303K Variant. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052770
BibTeX
@article{Efremova2024,
author = {Efremova, Anna and Kashirskaya, Nataliya and Krasovskiy, Stanislav and Melyanovskaya, Yuliya and Krasnova, Maria and Mokrousova, Diana and Bulatenko, Nataliya and Kondratyeva, Elena and Makhnach, Oleg and Bukharova, Tatiana and Zinchenko, Rena and Kutsev, Sergey and Goldshtein, Dmitry},
title = {Comprehensive Assessment of CFTR Modulators’ Therapeutic Efficiency for N1303K Variant},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052770}
}
EUVIMED